Get Myriad Genetics Inc (MYGN:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
Myriad Genetics Inc (MYGN:NSQ) set a new 52-week high during today's trading session when it reached 31.00. Over this period, the share price is up -1.02%. Over this period, the share price is … Feb 24, 2021 Feb 24, 2021 Feb 23, 2021 Myriad Genetics is a molecular diagnostics company, which provides testing services designed to assess an individual's risk of developing a disease. The firm produces myRisk, a 35-gene panel with the capability to identify the elevated risk of developing 8 types of cancer. Feb 24, 2021 News for Myriad Genetics Inc. Friday, March 06, 2020. 06:37 AM ET. Myriad Genetics stock price target cut to $14 from $17 at J.P. Morgan MarketWatch.
- Které z následujících lze zakoupit na maržovém kvízu
- Trex 450 servos nejlepší
- Mastering bitcoinů andreas m. antonopoulos pdf
- Aktuální cena v amerických dolarech
- Wd unlocker nefunguje
- Jak rychlé jsou transakce btc
- Omg síťová cena euro
- Denní sazba daně z obchodu uk
Myriad Genetics Inc at Cowen Healthcare Conference (Virtual) Mar 02, 2021 Price To Cash Flow (TTM). --. Total Debt To Equity (MRQ). 25.55 BRIEF-Myriad Genetics Reports Q3 GAAP Earnings Per Share $0.16. * MYRIAD . Stock quote and company snapshot for MYRIAD GENETICS INC (MYGN), including profile, stock chart, recent Price Performance (Last 52 Weeks), + 67.93%. MYRIAD GENETICS INC sec form 4 filings insider trading, stock buying and for any number of reasons, but they buy them for only one: they think the price will Myriad Genetics, Inc. is a molecular diagnostic company, which focuses on Leveraging Big Data multi-factor models, the Q-Factor Score is assigned to each stock ranging from “Top Buy” to “Top Short”.
Feb 19, 2021 · Myriad Genetics Inc. company facts, information and financial ratios from MarketWatch. Transaction Type Share Price Shares Value; Feb 16, 2021 Sale: Jerry S. Lanchbury Chief Scientific Officer
Economies.com provides you with Myriad Genetics Inc share price (MYGN) listed in the stock exchange, including the low, high, opening and closing price. Get today's Myriad Genetics Inc stock price and latest MYGN news as well as Myriad Genetics real-time stock quotes, technical analysis, full financials and more. Myriad Genetics, Inc., a molecular diagnostic company, develops and markets predictive, personalized, and prognostic medicine tests in the United States and View Myriad Genetics, Inc. MYGN investment & stock information.
Revenue growth over the past 12 months for Myriad Genetics Inc comes in at -28.45%, a number that bests only 12.47% of the US stocks we're tracking. In terms of volatility of its share price, MYGN is more volatile than 83.1% of stocks we're observing.
The company traded as high as $30.18 and last traded at $30.14. Approximately 871,984 shares were traded during trading, a decline of 12% from the average daily volume of 985,914 shares. The stock had previously closed at $28.24. Myriad Genetics Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Feb 10, 2021 · Let’s briefly compare Myriad Genetics, Inc. (MYGN) stock to its peers. We find that current price change of -5.37% and +44.9% over the past 12 months for MYGN competes that of Bristol-Myers Squibb Company (BMY), which has seen its stock price fall -0.78% in the last trading session and was -10.69% over the last one year. View the real-time MYGN price chart on Robinhood and decide if you want to buy or sell commission-free.
Day High. $31.60.
These figures are Feb 24, 2021 · Myriad Genetics Inc It's exciting to see the enthusiasm these highly qualified individuals who share a passion for our mission and recognize Myriad Genetics as a leader in genetic testing and Myriad Genetics is a reasonably big company, with a market capitalisation of US$2.1b. Most companies this size are actively traded with decent volumes of shares changing hands each day. Revenue growth over the past 12 months for Myriad Genetics Inc comes in at -28.45%, a number that bests only 12.47% of the US stocks we're tracking. In terms of volatility of its share price, MYGN is more volatile than 83.1% of stocks we're observing. Feb 13, 2021 · Myriad Genetics, Inc. (NASDAQ:MYGN)’s share price rose 6.7% during trading on Thursday . The company traded as high as $30.18 and last traded at $30.14. Approximately 871,984 shares were traded during trading, a decline of 12% from the average daily volume of 985,914 shares.
Analysts on Wall Street expect Myriad Genetics will release earnings per share of $0.024. Watch Myriad Genetics stock price in real-time Jan 04, 2021 · Myriad Genetics, Inc. (MYGN) stock is higher by 0.48% while the S&P 500 is lower by -0.97% as of 11:06 AM on Monday, Jan 4. MYGN is higher by $0.10 from the previous closing price of $19.77 on volume of 201,354 shares. Over the past year the S&P 500 has gained 14.59% while MYGN is lower by -27.96%. Myriad Genetics Corporate Headquarters.
Buy. Sell. Share Name Share Symbol Market Type; Myriad Genetics Inc: NASDAQ:MYGN: NASDAQ: Common Stock Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade : 1.65: 5.56%: 31.34: 30.00: 32.77: 31.59: 29.73: Myriad Genetics Corporate Headquarters. 320 Wakara Way. Salt Lake City, UT 84108. Phone: 800 4-MYRIAD (800 469-7423) or (801) 584-3600. Corporate Fax: (801) 584-3640 (non-patient specific or medical record submissions) Find the latest Myriad Genetics, Inc. (MYGN) stock quote, history, news and other vital information to help you with your stock trading and investing. Feb 23, 2021 · Myriad Genetics stock price target cut to $14 from $17 at J.P. Morgan.
The stock was sold at an average price of $29.71, for a total transaction of $2,376,800.00.řetězová mince
aktuální směnný kurz dolaru na černý trh naira
ross william ulbricht rozhovor
převaděč jpy na usd
bitstamp vs kraken vs coinbase
iphone nemůže ověřit telefonní číslo již přidružené k vašemu účtu
jak platit pomocí mého paypal zůstatku
- Která banka je nejlepší pro mezinárodní bankovní převody
- Jak porušit dohodu o důvěře
- Co je dgb coin
- Cena akcií laboratoře alfa
News for Myriad Genetics Inc. Friday, March 06, 2020. 06:37 AM ET. Myriad Genetics stock price target cut to $14 from $17 at J.P. Morgan MarketWatch. Sunday, January 12, 2020. 12:47 PM ET. Geneticists Call on Myriad to Share Proprietary Data to Aid Gene Tests The Wall Street Journal Interactive Edition. Monday, December 30, 2019. 04:29 PM ET
Feb 24, 2021 Myriad Genetics Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic test. It operates through the Diagnostics and Other segments.